McLeod Health using blood plasma from recovered COVID-19 patients to save lives
CHERAW, South Carolina) — McLeod Health physicians and clinical staff are testing the effectiveness and outcomes of convalescent blood plasma to treat critically ill Covid-19 patients.
The Infectious Diseases and Critical Care teams at McLeod Health are participating in this trial led and developed by the United States government and Mayo Clinic. This treatment, developed from the blood plasma of fully recovered COVID-19 patients, is given to hospitalized patients with severe cases of COVID-19. READ MORE